Tinzaparin sodium (Innohep®)
All Wales Medicines Strategy Group (AWMSG)
Record ID 32015001229
English
Authors' recommendations:
Tinzaparin sodium (innohep® Syringe) is recommended as an option for use within NHS Wales for the extended treatment of symptomatic venous thromboembolism and prevention of its recurrence in adult patients with solid tumours.
Details
Project Status:
Completed
Year Published:
2015
URL for published report:
http://www.awmsg.org/awmsgonline/app/appraisalinfo/2369
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Wales, United Kingdom
MeSH Terms
- Humans
- Venous Thromboembolism
- Heparin, Low-Molecular-Weight
- Adult
- Neoplasms
- Recurrence
Contact
Organisation Name:
All Wales Medicines Strategy Group
Contact Address:
All Wales Therapeutics and Toxicology Centre, Academic Centre, University Hospital Llandough, Penlan Road, Penarth, Vale of Glamorgan CF64 2XX
Contact Name:
AWTTC@wales.nhs.uk
Contact Email:
AWTTC@wales.nhs.uk
Copyright:
AWTTC
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.